Purine Release, Metabolism, and Signaling in the Inflammatory Response

Annu Rev Immunol. 2019 Apr 26:37:325-347. doi: 10.1146/annurev-immunol-051116-052406. Epub 2019 Jan 24.

Abstract

ATP, NAD+, and nucleic acids are abundant purines that, in addition to having critical intracellular functions, have evolved extracellular roles as danger signals released in response to cell lysis, apoptosis, degranulation, or membrane pore formation. In general ATP and NAD+ have excitatory and adenosine has anti-inflammatory effects on immune cells. This review focuses on recent advances in our understanding of purine release mechanisms, ectoenzymes that metabolize purines (CD38, CD39, CD73, ENPP1, and ENPP2/autotaxin), and signaling by key P2 purinergic receptors (P2X7, P2Y2, and P2Y12). In addition to metabolizing ATP or NAD+, some purinergic ectoenzymes metabolize other inflammatory modulators, notably lysophosphatidic acid and cyclic GMP-AMP (cGAMP). Also discussed are extracellular signaling effects of NAD+ mediated by ADP-ribosylation, and epigenetic effects of intracellular adenosine mediated by modification of S-adenosylmethionine-dependent DNA methylation.

Keywords: ADP-ribosylation; DNA methylation; NAD; NLRP3 inflammasome; P2X receptors; P2Y receptors; adenosine receptors; autotaxin; cGAMP; ectonucleotidases; lysophosphatidic acid; pannexin 1.

Publication types

  • Review

MeSH terms

  • ADP-Ribosylation
  • Adenosine Triphosphate / metabolism
  • Animals
  • DNA Methylation
  • Humans
  • Inflammation / genetics
  • Inflammation / immunology*
  • Inflammation / metabolism
  • Lysophospholipids / metabolism
  • Purines / metabolism*
  • Receptors, Purinergic / metabolism*
  • Signal Transduction

Substances

  • Lysophospholipids
  • Purines
  • Receptors, Purinergic
  • Adenosine Triphosphate
  • lysophosphatidic acid